Bal Pharma Ltd

NSE :BALPHARMA BSE :524824 Sector : Pharmaceuticals

Buy, Sell or Hold BALPHARMA? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

26 Apr
100.30
(2.03%)

25 Apr
98.30
(-2.29%)

24 Apr
100.60
(-0.64%)

23 Apr
101.25
(3.00%)

22 Apr
98.30
(0.61%)

19 Apr
97.70
(-2.40%)

18 Apr
100.10
(1.78%)

16 Apr
98.35
(-1.01%)

15 Apr
99.35
(-2.50%)

12 Apr
101.90
(-0.97%)

10 Apr
102.90
(1.18%)

09 Apr
101.70
(-2.07%)

08 Apr
103.85
(0.58%)

05 Apr
103.25
(0.73%)

04 Apr
102.50
(2.50%)

03 Apr
100.00
(0.15%)

02 Apr
99.85
(3.15%)

01 Apr
96.80
(6.14%)

28 Mar
91.20
(-4.15%)

27 Mar
95.15
(-3.74%)

26 Mar
98.85
(-0.05%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bullish

Medium Term Investors

Bearish

Long Term Investors

Neutral

Moving Averages

5 DMA

Bullish

99.86

10 DMA

Bullish

99.69

20 DMA

Bullish

99.77

50 DMA

Bearish

104.57

100 DMA

Bearish

108.09

200 DMA

Bearish

101.82

Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Apr 26, 2024 04:00 PM For Next Trading Session

Pivots	Classic	Fibonacci	Camarilla	Woodie	DM
R3	103.41	102.03	100.92	-	-
R2	102.03	101.17	100.71	102.16	-
R1	101.16	100.64	100.51	101.42	101.6
P	99.78	99.78	99.78	99.91	100
S1	98.91	98.92	100.09	99.17	99.35
S2	97.53	98.39	99.89	97.66	-
S3	96.66	97.53	99.68	-	-

Key Metrics

EPS

3.91

P/E

25.62

P/B

1.63

Dividend Yield

0.99%

Market Cap

159 Cr.

Face Value

10

Book Value

61.62

ROE

4.28%

EBITDA Growth

6.89 Cr.

Debt/Equity

1.92 Shareholding Pattern

	51.23%	Total Promoter Holding

	0%	Mutual Fund Holdings

	0.13%	FIIs

	48.64%	Non Institution

	0%	Insurance Companies

	0%	Custodians

	0%	Other Parties

Shareholding History

Bal Pharma Ltd Quaterly Results

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
INCOME	77.08	82.64	70.54	92.68	81.76
PROFIT	0.57	1.6	0.08	0.95	0.89
EPS	0.38	1.03	0.06	0.62	0.54

Bal Pharma Ltd Quaterly Results

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
INCOME	77.34	82.41	70.61	92.71	81.75
PROFIT	1.47	2.12	1.2	1.6	1.26
EPS	0.94	1.35	0.76	1.02	0.8

Profit & Loss (Figures in Rs. Crores)

Consolidated
Standalone

Bal Pharma Ltd Profit & Loss

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
INCOME	178.56	191.52	200.06	238.3	224.41	230.33	169.56	246.62	291.25	323.03
PROFIT	5.07	3.62	1.4	1.76	2.78	3.79	-12.27	4.72	4.98	2.55
EPS	4.4	2.56	0.2	0	0.27	1.52	-9.1	3.18	3.85	1.67

Bal Pharma Ltd Profit & Loss

	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
INCOME	178.56	191.47	199.53	235.48	222.76	230.24	170.98	246.87	291.71	323.15
PROFIT	5.07	4.01	2.8	5.31	5.94	6.76	-8.9	9.06	7.8	6.1
EPS	4.4	2.93	1.96	3.55	4.19	4.77	-6.28	6.14	5.79	3.9

Balance Sheet (Figures in Rs. Crores)

Consolidated
Standalone

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
SOURCES OF FUNDS :
Share Capital	15.69	14.82	14.82	14.17	14.17	14.17	14.17	12.87	12.87	11.11
Reserves Total	48.1	42.87	37.82	38.25	52.47	50.82	48.27	40.01	40.31	37.2
Equity Share Warrants	0	0.94	0	0	0	0	0	2.02	2.02	1.74
Equity Application Money	0	0	0.94	0	0	0	0	0	0	0
Total Shareholders Funds	63.79	58.63	53.58	52.42	66.64	64.99	62.44	54.9	55.2	50.05
Minority Interest	-0.09	-0.13	-0.23	-7.1	-6.42	-4.79	-2.38	-0.18	-0.03	0
Secured Loans	124.68	97.71	104.04	98.63	115.35	101.53	93.11	67.68	47.68	48.75
Unsecured Loans	6.32	5.93	5.98	19.82	8.15	8	0	21.08	1.81	1.97
Total Debt	131	103.64	110.02	118.45	123.5	109.53	93.11	88.76	49.49	50.72
Other Liabilities	6.74	8.78	7.63	6.83	4.91	3.33	3.42	3.18	2.4	1.72
Total Liabilities	201.44	170.92	171	170.6	188.63	173.06	156.59	146.66	107.06	102.49
APPLICATION OF FUNDS :
Gross Block	127.1	111.45	105.1	97.7	89.76	84.71	66.44	106.1	95.14	90.11
Less: Accumulated Depreciation	50.64	44.06	36.52	27	19.37	13.23	6.46	49.87	42.95	34.93
Net Block	76.46	67.39	68.58	70.7	70.39	71.48	59.98	56.23	52.19	55.18
Capital Work in Progress	0	1.61	0	3.32	3.63	0.21	1.7	3.93	0.77	0.25
Investments	0	0	0	0	0.02	0.02	0.02	0.02	0.02	0.02
Inventories	98.01	74.4	60.39	67.71	69.75	66.49	54.73	41.75	35.82	31.71
Sundry Debtors	93.98	75.31	67.2	49.6	64.7	64.05	61.8	56.94	44.98	45.49
Cash and Bank Balance	7.61	5.39	3.85	3.13	4.32	4.15	4.71	4.63	5.49	3.02
Loans and Advances	28.56	29.47	32.72	36.92	44.28	50.07	43.31	39.67	18.83	14.89
Total Current Assets	228.15	184.57	164.15	157.37	183.05	184.77	164.55	143	105.12	95.12
Current Liabilities	102.22	83.9	65.47	63.68	67.53	77.17	66.64	55.15	47.69	42.19
Provisions	6.64	5.12	0.98	0.5	0.96	2.37	1.29	2.24	1.83	1.83
Total Current Liabilities & Provisions	108.86	89.02	66.45	64.18	68.49	79.54	67.93	57.39	49.52	44.02
Net Current Assets	119.3	95.55	97.7	93.19	114.55	105.22	96.62	85.61	55.6	51.1
Deferred Tax Assets	2.17	0.09	0.95	3.9	1.64	0.96	1.17	1.01	0.81	-6.66
Deferred Tax Liability	2.87	0.69	3.58	7.49	5.82	8.53	9.97	7.99	8.1	1.58
Net Deferred Tax	-0.7	-0.6	-2.63	-3.59	-4.18	-7.57	-8.8	-6.98	-7.29	-8.24
Other Assets	6.39	6.96	7.35	6.99	4.23	3.7	7.07	7.86	5.76	4.19
Total Assets	201.45	170.92	171.01	170.62	188.64	173.06	156.6	146.67	107.06	102.49
Contingent Liabilities	16.44	16.25	12.99	12.99	20.29	7.75	12.26	0	14.93	0

	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
SOURCES OF FUNDS :
Share Capital	15.69	14.82	14.82	14.17	14.17	14.17	14.17	12.87	12.87	11.11
Reserves Total	80.34	71.56	63.56	51.77	62.69	58.06	52.41	41.81	40.71	37.2
Equity Share Warrants	0	0	0	0	0	0	0	2.02	2.02	1.74
Equity Application Money	0	0.94	0.94	0	0	0	0	0	0	0
Total Shareholders Funds	96.03	87.32	79.32	65.94	76.86	72.23	66.58	56.7	55.6	50.05
Secured Loans	125.23	98.01	104.04	98.63	96.33	82.51	74.09	67.68	47.68	48.75
Unsecured Loans	0	0	0.21	0.8	8.15	8	0	2.06	1.81	1.97
Total Debt	125.23	98.01	104.25	99.43	104.48	90.51	74.09	69.74	49.49	50.72
Other Liabilities	6.13	6.86	7.01	6.22	4.31	3.29	4.39	3.13	2.4	1.72
Total Liabilities	227.39	192.19	190.58	171.59	185.65	166.03	145.06	129.57	107.49	102.49
APPLICATION OF FUNDS :
Gross Block	107.22	92.12	86.13	82.36	76.19	71.43	66.18	105.77	96	91.28
Less : Accumulated Depreciation	44.15	39.22	33.48	26.23	19.25	13.15	6.46	49.82	44.1	36.1
Net Block	63.07	52.9	52.65	56.13	56.94	58.28	59.72	55.95	51.9	55.18
Capital Work in Progress	0	1.16	0	0.11	0.06	0.21	1.7	3.93	0.77	0.25
Investments	8.4	8.4	8.4	7.42	7.44	7.44	0.02	1.18	1.1	0.02
Inventories	97.69	73.97	60.12	67.55	69.52	66.17	54.37	41.61	35.77	31.71
Sundry Debtors	94.84	77.91	69.44	51.66	65.69	64.06	61.01	56.82	44.99	45.49
Cash and Bank Balance	7.35	5.09	3.72	2.95	4.08	4.03	4.61	4.46	4.54	3.02
Loans and Advances	70.07	61.23	59.92	46.55	49.21	47.23	30.37	21.54	19.35	14.89
Total Current Assets	269.95	218.2	193.2	168.71	188.5	181.48	150.35	124.44	104.65	95.12
Current Liabilities	110.82	89.97	65.59	63.17	66.38	75.13	64.74	54.56	47.56	42.19
Provisions	6.63	5.14	0.97	0.49	0.96	2.37	1.29	2.24	1.83	1.83
Total Current Liabilities & Provisions	117.45	95.12	66.56	63.66	67.33	77.5	66.03	56.8	49.39	44.02
Net Current Assets	152.5	123.08	126.64	105.05	121.17	103.99	84.32	67.64	55.26	51.1
Deferred Tax Assets	2.72	2.72	0	0	0	0.96	1.17	1.01	0.81	0.63
Deferred Tax Liability	5.58	5.18	4.4	4.05	4.18	8.52	8.91	7.97	8.09	8.87
Net Deferred Tax	-2.86	-2.46	-4.4	-4.05	-4.18	-7.56	-7.74	-6.96	-7.28	-8.24
Other Assets	6.29	9.1	7.29	6.94	4.22	3.68	7.05	7.84	5.73	4.19
Total Assets	227.4	192.18	190.58	171.6	185.65	166.05	145.08	129.58	107.48	102.49
Contingent Liabilities	16.44	16.25	13.86	12.99	20.29	7.75	0	14.65	14.93	0

Cash Flow (Figures in Rs. Crores)

Consolidated
Standalone

Cash from Operating Activity -1.84

Net Profit before Tax and Extr...	4.75
Depreciation	9.13
Interest (Net)	12.05
P/L on Sales of Assets	-0.03
Prov. and W/O (Net)	0.43
P/L in Forex	0.82
Fin. Lease and Rental Charges	-0.95
Others	-0.46
Total Adjustments (PBT and Ext...	21.44
Operating Profit before Workin...	26.19
Trade and 0ther Receivables	-31.89
Inventories	-23.61
Trade Payables	26.91
Loans and Advances	-7.95
Total Adjustments (OP before W...	-27.52
Cash Generated from/(used in) ...	-1.34
Direct Taxes Paid	-0.5
Total Adjustments(Cash Generat...	-0.5
Cash Flow before Extraordinary...	-1.84
Net Cash from Operating Activi...	-1.84

Cash from Investing Activity -22.18

Purchased of Fixed Assets	-14.65
Interest Received	0.14
Net Cash used in Investing Act...	-22.18

Cash from Financing Activity 24.4

Proceeds from Issue of shares ...	4.37
Proceed from 0ther Long Term B...	11.7
Proceed from Short Tem Borrowi...	23.72
Dividend Paid	-1.56
Interest Paid	-13.38
Net Cash used in Financing Act...	24.4

Cash from Operating Activity 5.07

Net Profit before Tax and Extr...	8.55
Depreciation	7.48
Interest (Net)	10.83
P/L on Sales of Assets	-0.04
Prov. and W/O (Net)	0.18
P/L in Forex	0.82
Fin. Lease and Rental Charges	-0.95
Others	-0.46
Total Adjustments (PBT and Ext...	18.55
Operating Profit before Workin...	27.1
Trade and 0ther Receivables	-17.93
Inventories	-23.71
Trade Payables	18.58
Loans and Advances	0.18
Total Adjustments (OP before W...	-21.52
Cash Generated from/(used in) ...	5.57
Direct Taxes Paid	-0.5
Total Adjustments(Cash Generat...	-0.5
Cash Flow before Extraordinary...	5.07
Net Cash from Operating Activi...	5.07

Cash from Investing Activity -22.08

Purchased of Fixed Assets	-14.54
Interest Received	0.13
Inter Corporate Deposits	-6.87
Net Cash used in Investing Act...	-22.08

Cash from Financing Activity 17.43

Proceeds from Issue of shares ...	4.37
Proceed from 0ther Long Term B...	3.51
Proceed from Short Tem Borrowi...	23.72
Dividend Paid	-1.56
Interest Paid	-12.16
Net Cash used in Financing Act...	17.43

Company Details

Registered Office
Address	21 & 22 Bommasandra Indl Area, Hosur Road
City	Bangalore
State	Karnataka
Pin Code	560092
Tel. No.
Fax. No.
Email	investor@balpharma.com
Internet	http://www.balpharma.com

Registrars
Address	21 & 22 Bommasandra Indl Area
City	Bangalore
State	Karnataka
Pin Code	560092
Tel. No.
Fax. No.
Email	investor@balpharma.com
Internet	http://www.balpharma.com

Management
Name	Designation
Shailesh Siroya	Managing Director
C V Srinivas	Independent Director
Himesh Virupakshaya	Executive Director
H S Venkatesh	Independent Director
Nicola Neeladri	Independent Director
Jatish Sheth	Independent Director
Kotian Chittananda Damodar	Whole-time Director
Abdul Basith	Company Sec. & Compli. Officer

MARKET TODAY

PRODUCTS

SUPPORT

LEGAL & PRIVACY

MAGAZINES

Stocks: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Data is a real-time snapshot *Data is delayed by at least 15 minutes. StockFact, Market Action Data and Analysis. Data Provider CMOTS Infotech.

Disclaimer : There is no guarantee of profits or no exceptions from losses. The investment advice provided is solely the personal views of the research team. Equitypandit will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Therefore, Equitypandit doesn't bear any responsibility for any trading losses you might incur as a result of using this data.

Bal Pharma Ltd

Buy, Sell or Hold BALPHARMA? Ask The Analyst

BSE

NSE

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bullish

Medium Term Investors

Bearish

Long Term Investors

Neutral

Moving Averages

5 DMA

Bullish

10 DMA

Bullish

20 DMA

Bullish

50 DMA

Bearish

100 DMA

Bearish

200 DMA

Bearish

Intraday Support and Resistance (Based on Pivot Points) |

Key Metrics

EPS

3.91

P/E

25.62

P/B

1.63

Dividend Yield

0.99%

Market Cap

159 Cr.

Face Value

10

Book Value

61.62

ROE

4.28%

EBITDA Growth

6.89 Cr.

Debt/Equity

1.92

Shareholding Pattern

Shareholding History

Quarterly Result (Figures in Rs. Crores)

Bal Pharma Ltd Quaterly Results

Bal Pharma Ltd Quaterly Results

Profit & Loss (Figures in Rs. Crores)

Bal Pharma Ltd Profit & Loss

Bal Pharma Ltd Profit & Loss

Balance Sheet (Figures in Rs. Crores)

Cash Flow (Figures in Rs. Crores)

Company Details

Registered Office

Registrars

Management

MARKET TODAY

PRODUCTS

SUPPORT

LEGAL & PRIVACY

MAGAZINES

Intraday Support and Resistance
(Based on Pivot Points) |